7/102 sources · 2 publishersUpdated Oct 19, 18:49 UTC
Medtronic wins European approval for five-device Vitalis pacemaker line
Medtronic received CE Mark approval for its Vitalis pacemaker family, which uses conduction system pacing. The five-device group includes ReSyncra CSP, Restoria CSP, Refina CSP, Effectra and Confirma, with ReSyncra CSP aimed at patients who may need resynchronization after conventional treatment has been ineffective.
Why it matters
The CE Mark gives Medtronic a European regulatory clearance for the Vitalis devices. The products also offer remote and in-office monitoring, expanding the available pacing options for eligible patients and clinicians.
Key facts
- 1The Vitalis family consists of five pacemakers: ReSyncra CSP, Restoria CSP, Refina CSP, Effectra and Confirma. massdevice.com
- 2Medtronic received CE Mark approval for the Vitalis pacemaker family. massdevice.com
- 3ReSyncra CSP is intended for patients who may benefit from cardiac resynchronization therapy but have not responded successfully to conventional approaches. vermoegenszentrum.ch
- 4The dual-chamber ReSyncra CSP, Restoria CSP and Refina CSP include Medtronic’s CSP MVP feature and support remote and in-office monitoring. massdevice.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.